Minowei is a new drug developer in the field of psychiatry and medical beauty, focusing on the development of new drugs in the field of spiritual and medical beauty to improve the quality of life of patients. It has completed the A round of financing exceeding 100 million yuan in July this year. This round of financing was jointly led by Huagai Capital, Lize Capital and Gimpo Health, and the original shareholders Yuanhe Yuandian and Wenzhou Investment continued to make additional investments. It is reported that the funds from this round of financing will be mainly used to promote the preclinical research and clinical development of Minovi Pharmaceuticals’ innovative drugs in the field of traumatic diseases and psychiatric diseases.
This article is reproduced from: https://www.itjuzi.com/investevent/13372601
This site is for inclusion only, and the copyright belongs to the original author.